These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31514285)

  • 1. Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions.
    Kovanen PT
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport.
    Lee-Rueckert M; Kovanen PT
    Atherosclerosis; 2006 Nov; 189(1):8-18. PubMed ID: 16530202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mast cells in atherosclerosis.
    Wezel A; Quax PH; Kuiper J; Bot I
    Hamostaseologie; 2015; 35(2):113-20. PubMed ID: 25377048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chymase-containing mast cells in human arterial intima: implications for atherosclerotic disease.
    Kovanen PT
    Heart Vessels; 1997; Suppl 12():125-7. PubMed ID: 9476562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells in atherosclerotic cardiovascular disease - Activators and actions.
    Kovanen PT; Bot I
    Eur J Pharmacol; 2017 Dec; 816():37-46. PubMed ID: 29032103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mast cells in atherosclerosis.
    Metzler B; Xu Q
    Int Arch Allergy Immunol; 1997 Sep; 114(1):10-4. PubMed ID: 9303325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding.
    Maaninka K; Nguyen SD; Mäyränpää MI; Plihtari R; Rajamäki K; Lindsberg PJ; Kovanen PT; Öörni K
    Atherosclerosis; 2018 Aug; 275():390-399. PubMed ID: 29703634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid droplet-associated proteins in atherosclerosis (Review).
    Plakkal Ayyappan J; Paul A; Goo YH
    Mol Med Rep; 2016 Jun; 13(6):4527-34. PubMed ID: 27082419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis.
    Aliev G; Burnstock G
    Histol Histopathol; 1998 Jul; 13(3):797-817. PubMed ID: 9690137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular mast cell granules carry apolipoprotein B-100-containing lipoproteins into phagocytes in human arterial intima. Functional coupling of exocytosis and phagodytosis in neighboring cells.
    Kaartinen M; Penttilä A; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):2047-54. PubMed ID: 7583588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mast cell as a pluripotent HDL-modifying effector in atherogenesis: from in vitro to in vivo significance.
    Lee-Rueckert M; Kovanen PT
    Curr Opin Lipidol; 2015 Oct; 26(5):362-8. PubMed ID: 26339766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells.
    Chen C; Khismatullin DB
    PLoS One; 2015; 10(3):e0123088. PubMed ID: 25811595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell granule-mediated uptake of low density lipoproteins by macrophages: a novel carrier mechanism leading to the formation of foam cells.
    Kovanen PT
    Ann Med; 1991; 23(5):551-9. PubMed ID: 1756025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the pathogenesis of atherosclerosis.
    Wissler RW
    Am J Med; 1991 Jul; 91(1B):3S-9S. PubMed ID: 1867233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.